<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1337">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04525417</url>
  </required_header>
  <id_info>
    <org_study_id>GERES20200409</org_study_id>
    <secondary_id>ID RCB 2020-A01031-38</secondary_id>
    <nct_id>NCT04525417</nct_id>
  </id_info>
  <brief_title>Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers</brief_title>
  <official_title>Use of Rapid Covid-19 Antibody Test Marketed by AAZ Laboratories in Healthcare Workers Presumably Being Infected by SARS-CoV-2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objectives were to assess 1/the immune status of healthcare professionals with
      suggestive symptomatology of Covid-19 infection and 2/the sensitivity and specificity of AAZ
      rapid test by comparing it with a serological ELISA test.

      An open-label, monocentric, prospective, non-randomized study, is conducted, including 50
      hospital healthcare professionals and 50 private health professionals.

      Knowledge of serostatus will achieve the implementation of a strategy of management of
      patients according to specific immunity of health professionals
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 25, 2020</start_date>
  <completion_date type="Anticipated">October 25, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 25, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Monocentric, open-label, prospective, non-randomized study</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the predictive value of Covid-19 rapid test</measure>
    <time_frame>One week</time_frame>
    <description>Comparative study with Elisa Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compare the results of rapid tests on serum and capillary samples</measure>
    <time_frame>one week</time_frame>
    <description>Performance evaluation of rapid tests according to the samples used</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>A posteriori diagnosis of a covid-19 recent infection with suggestive symptomatology</measure>
    <time_frame>one week</time_frame>
    <description>Use of rapid test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of factors associated with negativity of PCR test on oropharyngeal swabs and positive serology</measure>
    <time_frame>One week</time_frame>
    <description>Analysis of clinical data</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Covid-19 Immune Status of Healthcare Workers</condition>
  <arm_group>
    <arm_group_label>hospital healthcare workers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Clinical examination; Veinous blood sampling for serological testing; capillary drawing to perform a rapid Covid-19 test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>private health professionals</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Clinical examination; Veinous blood sampling for serological testing; capillary drawing to perform a rapid Covid-19 test</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>AAZ Covid-19 rapid test</intervention_name>
    <description>To assess the immune status</description>
    <arm_group_label>hospital healthcare workers</arm_group_label>
    <arm_group_label>private health professionals</arm_group_label>
    <other_name>ELISA test</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthcare professionals with symptoms suggestive of Covid-19 infection

        Exclusion Criteria:

          -  any other subject

          -  pregnant women

          -  protected adult
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisabeth Bouvet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elisabeth Bouvet, MD</last_name>
    <phone>+33 1 40 25 73 07</phone>
    <email>elisabeth.bouvet@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gerard Pellissier, PhD</last_name>
    <phone>+33 1 5727 7871</phone>
    <email>gerard.pellissier@geres.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bichat University Hospital</name>
      <address>
        <city>Paris</city>
        <zip>F-75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabeth Bouvet, MD</last_name>
      <phone>+33 1 40 25 73 07</phone>
      <email>elisabeth.bouvet@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Charlotte Charpentier, MD</last_name>
      <phone>+33 6 8673 3402</phone>
      <email>charlotte.charpentier@aphp.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 21, 2020</study_first_submitted>
  <study_first_submitted_qc>August 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2020</study_first_posted>
  <last_update_submitted>August 22, 2020</last_update_submitted>
  <last_update_submitted_qc>August 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

